A gain-of-function EZH2 mutation characterized by an aberrant H3K27me3 occupancy blocked B cell development and was found in several lymphomas [112,113], whereas a loss-of-function of EZH2 is common in myelodysplastic syndromes [114]. This evidence concerns the gene EZH2 and lymphoma.